Protein Crystallization & Crystallography Market Size [2031]

Protein Crystallization & Crystallography Market Size [2031]

Segments - Protein Crystallization & Crystallography Market by Technology (Spectroscopy, X-ray Crystallography, Small-angle X-ray Scattering, and Cryo-electron Microscopy), Product (Instruments and Consumables), End-user (Research & Government Institutes, Pharmaceutical & Biotechnology Companies, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vineet
Fact-checked by : Vineet Pandey
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-5907 | 4.7 Rating | 90 Reviews | 255 Pages | Format : PDF Excel PPT

Report Description


Protein Crystallization & Crystallography Market Outlook 2031

The global protein crystallization & crystallography market size was USD 1.59 Billion in 2022 and is likely to reach USD 3.65 Billion by 2031, expanding at a CAGR of 8.78% during 2023–2031. The market is propelled by the advancements in structural biology.

Growth of drug discovery and development is anticipated to boost the market during the assessment period. Protein crystallography is essential for drug discovery, as it helps in understanding the drug-protein interactions, thereby driving its adoption in the pharmaceutical industry. Furthermore, the biotechnology industry extensively relies on protein crystallography for drug development. As a result, the expansion of this industry is likely to fuel the market in the coming years.

  • As per a survey published in August 2023, biopharmaceutical companies are responsible for approximately 40% of global drug sales. Numerous mid to small-size biotech companies that were known mostly to the insiders of the industry are becoming apparent through their work in drug development and discovery during the pandemic.

Protein Crystallization and Crystallography Market Outlook

Protein crystallization is a crucial component of academic and research programs, which further contributes to market expansion. Studies focused on determining the 3D structure of a wide range of proteins is likely to boost the market.

Moreover, there is a high demand for protein structure analysis for not only finding new potential treatments but also for creating personalized medicines and targeted therapies. This is expected to propel the market in the coming period.


The COVID-19 pandemic fueled the market owing to the shortage of medicines that could treat the infection during COVID-19 treatment. The health crisis during that period led to a high rate of mortality. Consequently, there was a surge in demand for groundbreaking treatments that could prove to be effective against the infection. This led to the major propulsion of the market.

Impact of Artificial Intelligence (AI) in Protein Crystallization & Crystallography Market

The use of artificial intelligence is likely to provide substantial propulsion to the protein crystallization & crystallography market. The use of artificial intelligence has transformed the field of protein crystallization & crystallography by simplifying the identification of protein structures.

By leveraging machine learning algorithms, it has become significantly easier to accurately identify diverse molecular structures. This has led to significant strides in the drug discovery and development of therapeutics. Consequently, the use of AI is expected to considerably propel the market in the coming years.

Protein Crystallization & Crystallography Market Dynamics

Protein Crystallization and Crystallography Market Dynamics

Major Drivers

Surge in the requirement for protein therapeutics is expected to drive the market during the projection period. Protein therapies have become a vital part of the healthcare advancement. Owing to their specificity and low immunogenicity, these therapies are being extensively implemented to treat several types of severe ailments including cancer.

With the rise in the inclination of pharmaceutical and biopharmaceutical industries towards protein-based therapies, they are making substantial investments in research and development of such therapeutic practices. This is anticipated to propel the market in the coming years.

  • In January 2022, Amgen collaborated with Generate Biomedicines to discover and create protein therapies. This has been done keeping in focus five clinical targets across various therapeutic areas and several domains.

Existing Restraints

Major complexity in protein crystallization is likely to hamper the market during the forecast period. Premium quality protein crystals are important for both X-ray formulation development and crystallography. It requires a highly pure and concentrated sample of protein.

The fluid portion of the solution evaporates, leaving behind protein crystals. This process is very complex to carry out and requires very precise mixing and measurement. This is projected to impede the market during the forecast period.

Emerging Opportunities

Advancements in technology are anticipated to provide substantial growth opportunities for the market. There have been substantial technological developments in the methods of crystallization in recent years methods, including cell-free protein crystallization.

The technology plays a significant role in the progress of structural biology by enabling the analysis of unstable proteins that can't be studied through standard techniques. These advancements promote the development of enhanced protein crystal treatments for various diseases including cancer and muscular dystrophy.

Scope of the Protein Crystallization & Crystallography Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Protein Crystallization & Crystallography Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Technology (Spectroscopy, X-ray Crystallography, Small-angle X-ray Scattering, and Cryo-electron Microscopy), Product (Instruments, Consumables, and Software & Services), End-user (Research & Government Institutes, Pharmaceutical & Biotechnology Companies, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

Rigaku Corporation and its Global Subsidiaries; Calibre Scientific; METTLER TOLED; Jena Bioscience GmbH; HAMPTON RESEARCH CORP.; Greiner Bio-One International GmbH; FORMULATRIX; Creative Proteomics; Corning Incorporated; and Bruker


Protein Crystallization & Crystallography Market Segment Insights

Technology Segment Analysis

Based on technology, the protein crystallization & crystallography market is divided into spectroscopy, X-ray crystallography, small-angle X-ray scattering, and cryo-electron microscopy. The x-ray crystallography segment is anticipated to capture the largest market share during the forecast period.

It is a technique used to determine the 3-dimensional, high-resolution molecules of proteins and has played a substantial role in advancing numerous scientific disciplines.
Digital X-ray crystallography measures chemical bond types and types, atom sizes, atomic-scale differences, crystalline integrity, grain size, grain orientation, and others. As a result, its use has significantly increased in recent years and is likely to create lucrative prospects for the market.

Protein Crystallization and Crystallography Market Technology

Product Segment Analysis

On the basis of product, the global market is segregated into instruments, consumables, and software & services. The consumables segment is anticipated to dominate the market revenue during the forecast period.

Consumables include kits, screens, reagents, and microplates, that support crystallization techniques. Protein crystallization kits provide an efficient screening technique to identify the ideal solubility conditions for protein crystallization. These kits contain chemicals required for quick screening to determine the optimal conditions for the crystallization of purified protein samples.


The software and services segment is anticipated to grow at a high CAGR during the forecast period. Software is used throughout the crystallization process, including analysis, design, dispensing, and image viewing. For example, the FORMULATRIX program ROCK MAKER enables the rapid creation of many screen assays for one or more proteins and assigns scores to aid in the comparison of collected images. This type of software capability is expected to drive segment growth over the forecast period.

End-user Segment Analysis

On the basis of end-user, the protein crystallization & crystallography market is segmented into research & government institutes, pharmaceutical & biotechnology companies, and others. The pharmaceutical & biotechnology companies segment is anticipated to register a robust growth rate during the forecast period as protein crystallography plays a crucial in drug design and discovery.

It produces precise 3-D protein structures that help understand disease mechanisms, create drugs effectively, and find therapeutic targets. Its success in developing transformative medicines such as HIV protease inhibitors and leukemia drug Gleevec. Consequently, this segment is anticipated to have major propulsion in the years to come.

  • In October 2022, Tokyo Tech, one of the leading key market players, introduced direct protein crystallization. It is a new technology for cell-free protein crystallization and opens the possibility of studying unstable proteins.

Regional Outlook

In terms of region, the global protein crystallization & crystallography market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period due to the advanced medical infrastructure and the presence of several prominent market players in this region.

Surge in technological advancements and the rise in R&D activities have led to the major development of pharmaceutical and
biopharmaceutical companies are anticipated to create lucrative opportunities for the market in this region.


The market in Asia Pacific is projected to witness considerable propulsion owing to the expansion of the pharmaceutical industry and industrial expansion in economies such as India and China. Other factors such as the rise in the overall population, increase in geriatric population in proportion, and increase in disposable income play a considerable role in strengthening the market.

Protein Crystallization and Crystallography Market Region

Segments

The protein crystallization & crystallography market has been segmented on the basis of

Technology

  • Spectroscopy
  • X-ray Crystallography
  • Small-angle X-ray Scattering
  • Cryo-electron Microscopy

Product

  • Instruments
  • Consumables
  • Software & Services

End-user

  • Research & Government Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

Competitive Landscape

Key players competing in the global protein crystallization & crystallography market are Rigaku Corporation and its Global Subsidiaries; Calibre Scientific; METTLER TOLED; Jena Bioscience GmbH; HAMPTON RESEARCH CORP.; Greiner Bio-One International GmbH; FORMULATRIX; Creative Proteomics; Corning Incorporated; and Bruker.

These companies implement several development strategies such as mergers, partnerships, product launches, collaboration, acquisitions, and production expansion to expand their consumer base worldwide. For instance,

  • In April 2022, Sygnature Discovery, one of the prominent market players, acquired Peak Proteins Ltd. This acquisition has been done after the two companies have had an extensive partnership. This step is intended to help in seamlessly integrating the structure determination projects and protein production within the company.

    Protein Crystallization and Crystallography Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Protein Crystallization & Crystallography Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Protein Crystallization & Crystallography Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Protein Crystallization & Crystallography Market - Supply Chain
  4.5. Global Protein Crystallization & Crystallography Market Forecast
     4.5.1. Protein Crystallization & Crystallography Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Protein Crystallization & Crystallography Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Protein Crystallization & Crystallography Market Absolute $ Opportunity
5. Global Protein Crystallization & Crystallography Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Protein Crystallization & Crystallography Market Size and Volume Forecast by End Users
     5.3.1. Research & Government Institutes
     5.3.2. Pharmaceutical & Biotechnology Companies
     5.3.3. Others
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Protein Crystallization & Crystallography Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Protein Crystallization & Crystallography Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Protein Crystallization & Crystallography Demand Share Forecast, 2019-2026
7. North America Protein Crystallization & Crystallography Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Protein Crystallization & Crystallography Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Protein Crystallization & Crystallography Market Size and Volume Forecast by End Users
     7.4.1. Research & Government Institutes
     7.4.2. Pharmaceutical & Biotechnology Companies
     7.4.3. Others
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Protein Crystallization & Crystallography Demand Share Forecast, 2019-2026
8. Latin America Protein Crystallization & Crystallography Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Protein Crystallization & Crystallography Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Protein Crystallization & Crystallography Market Size and Volume Forecast by End Users
     8.4.1. Research & Government Institutes
     8.4.2. Pharmaceutical & Biotechnology Companies
     8.4.3. Others
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Protein Crystallization & Crystallography Demand Share Forecast, 2019-2026
9. Europe Protein Crystallization & Crystallography Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Protein Crystallization & Crystallography Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Protein Crystallization & Crystallography Market Size and Volume Forecast by End Users
     9.4.1. Research & Government Institutes
     9.4.2. Pharmaceutical & Biotechnology Companies
     9.4.3. Others
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Protein Crystallization & Crystallography Demand Share Forecast, 2019-2026
10. Asia Pacific Protein Crystallization & Crystallography Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Protein Crystallization & Crystallography Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Protein Crystallization & Crystallography Market Size and Volume Forecast by End Users
     10.4.1. Research & Government Institutes
     10.4.2. Pharmaceutical & Biotechnology Companies
     10.4.3. Others
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Protein Crystallization & Crystallography Demand Share Forecast, 2019-2026
11. Middle East & Africa Protein Crystallization & Crystallography Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Protein Crystallization & Crystallography Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Protein Crystallization & Crystallography Market Size and Volume Forecast by End Users
     11.4.1. Research & Government Institutes
     11.4.2. Pharmaceutical & Biotechnology Companies
     11.4.3. Others
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Protein Crystallization & Crystallography Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Protein Crystallization & Crystallography Market: Market Share Analysis
  12.2. Protein Crystallization & Crystallography Distributors and Customers
  12.3. Protein Crystallization & Crystallography Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Rigaku Corporation and its Global Subsidiaries
     12.4.2. Calibre Scientific
     12.4.3. METTLER TOLED
     12.4.4. Jena Bioscience GmbH
     12.4.5. HAMPTON RESEARCH CORP.
     12.4.6. Greiner Bio-One International GmbH
     12.4.7. FORMULATRIX
     12.4.8. Creative Proteomics
     12.4.9. Corning Incorporated
     12.4.10. Bruker

Methodology

Our Clients

Dassault Aviation
Honda Motor Co. Ltd.
sinopec
General Mills
Deloitte
Microsoft
The John Holland Group
Nestle SA